Silence Therapeutics plcSLN stock score: 55/100

$19.81 · -0.05% · Scored Nov 19, 2026

Technical
66
Fundamental
53
News
44

The reading

Silence Therapeutics (SLN) scores 55 out of 100, which reads neutral, higher than 62% of Healthcare stocks and 61% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 53, technicals 66.

Among the fundamentals, Quick Ratio at 100 and Current Ratio at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 67 and contrarian oscillators 32 — a split worth reading before trusting the technical total.

News sentiment is neutral at 44; it is shown, not counted in the composite.

Since Aug 24, 2026 the composite has ranged from 44 to 59, and it ends the period where it started.

About Silence Therapeutics

Silence Therapeutics (SLN) is a London-based biotechnology company that develops RNA interference medicines, which silence specific genes in the liver to reduce production of disease-causing proteins. Its mRNAi GOLD platform links short interfering RNA molecules to a sugar that directs them to liver cells, allowing infrequent dosing. Its most advanced candidate, zerlasiran, is designed to lower lipoprotein(a), an inherited risk factor for heart disease, and the company has completed preparations for late-stage development and is seeking a partner to fund and run it. Its second program, divesiran, targets the TMPRSS6 gene to treat polycythemia vera, a rare blood cancer, by reducing excess red blood cell production. Silence has also worked with larger drug makers under research collaborations, earning upfront payments and milestones, and it funds its own programs largely with cash raised from investors. Its shares trade in the United States as American depositary shares.

In lipoprotein(a), Silence competes with Novartis, Amgen and Eli Lilly, which have their own candidates in late-stage trials, while in polycythemia vera it faces Incyte, Takeda and Protagonist Therapeutics, and other treatments. Its edge rests on a platform that has produced durable gene silencing in clinical trials and a pipeline aimed at large cardiovascular markets and rare blood disorders. Investors who follow SLN stock tend to watch partnering of zerlasiran. Clinical data from divesiran are closely followed. Collaboration income, cash runway and leadership changes are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward SLN’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

53

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

  • How the latest quarter's revenue compares with the average of the last four, plus a bonus for steady quarterly revenue.

Holding it back

28 weighted scorers; 11 had no data today and are left out rather than counted as zero.

Technical · daily

63

Pulling it up

  • Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

  • Exponential Moving Average (50-period) is a key intermediate-term trend indicator that responds more quickly than SMA-50.

  • Simple Moving Average (50-period) is a widely-watched intermediate-term trend gauge.

Holding it back

  • Williams %R (28-period) places the close within the last 28 periods' high-low range.

  • Relative Strength Index (14-period) measures momentum by comparing recent gains to losses.

  • Annualised volatility of the last 60 daily returns.

61 weighted scorers; 4 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
44

Technical score by timeframe

ChartScoreWeight
Hourly491
Daily633
Weekly702
Monthly752

Composite score, last 90 days

05010055Aug 24, 2026Nov 20, 2026Aug 24, 2026: 55Aug 25, 2026: 55Aug 26, 2026: 56Aug 27, 2026: 56Aug 28, 2026: 55Aug 29, 2026: 55Aug 30, 2026: 55Aug 31, 2026: 55Sep 1, 2026: 56Sep 2, 2026: 56Sep 3, 2026: 57Sep 4, 2026: 57Sep 5, 2026: 56Sep 6, 2026: 55Sep 7, 2026: 55Sep 8, 2026: 55Sep 9, 2026: 55Sep 10, 2026: 54Sep 11, 2026: 54Sep 12, 2026: 54Sep 13, 2026: 54Sep 14, 2026: 54Sep 15, 2026: 54Sep 16, 2026: 53Sep 17, 2026: 53Sep 18, 2026: 54Sep 19, 2026: 52Sep 20, 2026: 53Sep 21, 2026: 53Sep 22, 2026: 53Sep 23, 2026: 53Sep 24, 2026: 54Sep 25, 2026: 52Sep 26, 2026: 51Sep 27, 2026: 52Sep 28, 2026: 52Sep 29, 2026: 52Sep 30, 2026: 51Oct 1, 2026: 52Oct 2, 2026: 50Oct 3, 2026: 50Oct 4, 2026: 50Oct 5, 2026: 50Oct 6, 2026: 48Oct 7, 2026: 47Oct 8, 2026: 48Oct 9, 2026: 47Oct 10, 2026: 48Oct 11, 2026: 48Oct 12, 2026: 48Oct 13, 2026: 48Oct 14, 2026: 45Oct 15, 2026: 45Oct 16, 2026: 46Oct 17, 2026: 44Oct 18, 2026: 44Oct 19, 2026: 44Oct 20, 2026: 59Oct 21, 2026: 59Oct 22, 2026: 57Oct 23, 2026: 57Oct 24, 2026: 57Oct 25, 2026: 57Oct 26, 2026: 57Oct 27, 2026: 57Oct 28, 2026: 57Oct 29, 2026: 57Oct 30, 2026: 57Oct 31, 2026: 56Nov 2, 2026: 56Nov 3, 2026: 56Nov 4, 2026: 56Nov 5, 2026: 57Nov 6, 2026: 54Nov 7, 2026: 55Nov 8, 2026: 55Nov 11, 2026: 56Nov 12, 2026: 56Nov 13, 2026: 59Nov 14, 2026: 55Nov 15, 2026: 55Nov 16, 2026: 55Nov 18, 2026: 56Nov 19, 2026: 56Nov 20, 2026: 55
Show the daily numbers
DateComposite
Nov 20, 202655
Nov 19, 202656
Nov 18, 202656
Nov 16, 202655
Nov 15, 202655
Nov 14, 202655
Nov 13, 202659
Nov 12, 202656
Nov 11, 202656
Nov 8, 202655
Nov 7, 202655
Nov 6, 202654
Nov 5, 202657
Nov 4, 202656
Nov 3, 202656
Nov 2, 202656
Oct 31, 202656
Oct 30, 202657
Oct 29, 202657
Oct 28, 202657
Oct 27, 202657
Oct 26, 202657
Oct 25, 202657
Oct 24, 202657
Oct 23, 202657
Oct 22, 202657
Oct 21, 202659
Oct 20, 202659
Oct 19, 202644
Oct 18, 202644
Oct 17, 202644
Oct 16, 202646
Oct 15, 202645
Oct 14, 202645
Oct 13, 202648
Oct 12, 202648
Oct 11, 202648
Oct 10, 202648
Oct 9, 202647
Oct 8, 202648
Oct 7, 202647
Oct 6, 202648
Oct 5, 202650
Oct 4, 202650
Oct 3, 202650
Oct 2, 202650
Oct 1, 202652
Sep 30, 202651
Sep 29, 202652
Sep 28, 202652
Sep 27, 202652
Sep 26, 202651
Sep 25, 202652
Sep 24, 202654
Sep 23, 202653
Sep 22, 202653
Sep 21, 202653
Sep 20, 202653
Sep 19, 202652
Sep 18, 202654
Sep 17, 202653
Sep 16, 202653
Sep 15, 202654
Sep 14, 202654
Sep 13, 202654
Sep 12, 202654
Sep 11, 202654
Sep 10, 202654
Sep 9, 202655
Sep 8, 202655
Sep 7, 202655
Sep 6, 202655
Sep 5, 202656
Sep 4, 202657
Sep 3, 202657
Sep 2, 202656
Sep 1, 202656
Aug 31, 202655
Aug 30, 202655
Aug 29, 202655
Aug 28, 202655
Aug 27, 202656
Aug 26, 202656
Aug 25, 202655
Aug 24, 202655

Key facts

Market cap
$1.2B
Sector
Healthcare
Industry
Biotechnology
Beta
1.34
Risk grade (1–10)
—
Next earnings
Nov 12, 2026

Questions

What is SLN's stock rating today?

SLN scores 55/100 (Neutral) as of Nov 19, 2026: technical 66, fundamental 53, and news sentiment 44, which is shown but not counted. Scores are recomputed every night.

What does Silence Therapeutics do?

Silence Therapeutics (SLN) is a London-based biotechnology company that develops RNA interference medicines, which silence specific genes in the liver to reduce production of disease-causing proteins. Its mRNAi GOLD platform links short interfering RNA molecules to a sugar that directs them to liver cells, allowing infrequent dosing.

Is SLN stock a buy?

The score is not a buy or sell recommendation. A 55 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the SLN score calculated?

89 weighted scorers feed it today: 28 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

SLN stock score

HTML

<a href="https://stocksscores.com/stocks/sln/"><img src="https://stocksscores.com/stocks/sln/badge.svg" alt="SLN stock score" height="20"></a>

Markdown

[![SLN stock score](https://stocksscores.com/stocks/sln/badge.svg)](https://stocksscores.com/stocks/sln/)